Project Grant R43AG082546

Award Date 5/15/23
Completion Date 4/30/24
Dollars Obligated $500K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $864,674 to Lifebio Inc., a small disadvantaged business, to develop a tablet-based digital platform called LifeBioTalk. The platform is designed to provide stimulating audiovisual content narrated by a human-like avatar to engage people with Alzheimer's disease and related dementias (ADRD). The goal is for LifeBioTalk to reduce challenging behaviors and caregiver burden by...
This Project Grant award for $353,391.00, funded by the National Institute on Aging (CFDA 93.866 - Aging Research), aims to validate a digital tool called the Personal Learning Curve (PLC) for early detection and sensitive tracking of cognitive changes related to Alzheimer's disease (AD) in a representative sample of older adults at risk for AD and related dementias. The project will recruit 300 participants who have completed the active phase of the U.S. POINTER clinical trial on multi-domain...
This $349,333 Project Grant awarded by the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to develop and test the feasibility of a virtual reality (VR) platform to support and empower in-home dementia caregivers. The VR-CARES initiative, led by Rendever, Inc., will co-create the VR platform with caregivers to provide a virtual gathering place for social support, training, and shared experiences. The project will (1) draw on caregiver input...
This Project Grant award of $232,485 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to adapt and test the feasibility of an AI-enabled web app based on Acceptance and Commitment Therapy (ACT) for family caregivers of people with dementia. The key products and services to be delivered under this two-year award include: 1) Adapting an existing AI-enabled ACT web app for family caregivers through collaboration with a community advisory board, and 2) Evaluating the...
This National Institute on Aging (NIA) Project Grant award (CFDA 93.866 - Aging Research) provides funding of $356,974 to the Trustees of Indiana University to culturally adapt a mobile caregiver intervention for Hispanic individuals with Alzheimer's disease and related dementias (ADRD). The project aims to conduct a needs assessment with Hispanic ADRD informal caregivers to inform modifications to the "Brain CareNotes" mobile telehealth application, which is designed to help...
The federal Project Grant award of $499,996 from the National Institute on Aging's (NIA) Aging Research program (CFDA 93.866) is supporting the development of COMPASS, a family-centered, culturally responsive conversational AI assistant. The goal of COMPASS is to provide real-time support and coordination for diverse Alzheimer's disease and related dementia (ADRD) caregivers and their care networks. The 12-month Phase 1 project aims to develop a prototype of COMPASS and test its initial...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to assess cost and non-cost barriers to the use of novel Alzheimer's disease (AD) and related dementias (ADRD) therapeutics among older Hispanic or Latino adults. The $311,341 award will fund a two-phase project. The first planning phase will involve semi-structured interviews with Latino adults and patients with AD/ADRD and their caregivers to inform a subsequent population-based survey through the...
This $170,593 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) aims to develop and pilot test a feasible, acceptable, and usable online platform called iPath*D to improve screening and access to depression treatment for care partners of people living with Alzheimer's disease and related dementias. The project has two key objectives: 1) Optimize and assess the feasibility and acceptability of a screening pathway to identify at-risk care partners, and...
This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) will develop the ISMART (Intelligent Social Risk Management in AD/ADRD Patients) platform to improve care and quality of life for people living with dementia (PLWD), particularly those from racial-ethnic minority and socioeconomically disadvantaged groups. The $3,645,585 award to the University of Florida will leverage real-world data from electronic health records and contextual social...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,811,559 to the University of Massachusetts to conduct a study on using wearable devices and AI techniques to develop digital biomarkers for early detection of Alzheimer's disease. The key objectives are to: Deploy consumer wearables for sleep, heart rate, and activity monitoring in a cohort of older adults with elevated genetic risk for Alzheimer's to quantify device accuracy and develop...

DEVELOPING A PERSONALIZED AND CULTURALLY RESPONSIVE VIRTUAL COACH TO ENGAGE PERSONS WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS IN COGNITIVE AND PHYSICAL ACTIVITIES - PROJECT SUMMARY THE NUMBER OF AMERICANS LIVING WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS (ADRD) IS ESTIMATED TO DOUBLE TO 13.8 MILLION PEOPLE BY 2050, WITH MINORITIZED INDIVIDUALS AFFECTED DISPROPORTIONATELY. COGNITIVE, PHYSICAL, AND SOCIAL ACTIVITIES CAN IMPROVE QUALITY OF LIFE, COGNITION, AND BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD), BUT ACCESS, ENGAGEMENT, AND ADHERENCE ARE CHALLENGING. ADRD SPECIALISTS ARE EXPENSIVE AND INACCESSIBLE FOR DAILY SUPPORT, ESPECIALLY FOR PERSONS LIVING WITH DEMENTIA (PL WD) FROM MINORITIZED BACKGROUNDS WHO CANNOT FIND CULTURALLY COMPETENT PROVIDERS. SUPPORT GROUPS DO NOT PROVIDE SCALABLE, INDIVIDUALIZED, EVIDENCE-BASED SKILLS OR DAILY GUIDANCE, AND CAREGIVERS ARE ALREADY OVERBURDENED ASSISTING WITH ACTIVITIES OF DAILY LIVING. COMMERCIAL SOLUTIONS TO SUPPORT PLWD ARE NOT CULTURALLY RESPONSIVE OR SCALABLE FOR DAILY, AFFORDABLE USE. THERE IS AN INCREASINGLY UNMET NEED FOR CULTURALLY RELEVANT, ACCESSIBLE, AND SCALABLE ADRD CARE. WE ARE DEVELOPING A PERSONALIZED AND CULTURALLY RESPONSIVE VIRTUAL COACHING PLATFORM TO ENGAGE AND SUPPORT PLWD IN EVIDENCE-BASED COGNITIVE AND PHYSICAL ACTIVITIES IN ORDER TO ENHANCE HEALTH AND WELL-BEING. OUR NOVEL TECHNOLOGY LEVERAGES ADVANCES IN ARTIFICIAL INTELLIGENCE (AI) AND NATURAL LANGUAGE PROCESSING (NLP) TO FACILITATE ACTIVITIES FROM PEER-REVIEWED INTERVENTIONS AT LOWER COSTS. IN EACH SESSION, AN AVATAR IS USED TO GUIDE AND SUPPORT THE PLWD THROUGH EVIDENCE-BASED COGNITIVE AND PHYSICAL ACTIVITIES. TO ENGAGE PLWD, OUR NLP-BASED SYSTEM ADAPTS THE COACH'S DIALOGUE BASED ON INPUT SHARED BY THE PLWD AND THEIR FAMILY ON KEY ASPECTS OF THE PLWD'S LIFE HISTORY AND CULTURE (E.G., FAVORITE HOLIDAYS, MUSIC GENRES, FOODS). THE AVATAR COACH ALSO HAS CHARACTERISTICS TAILORED TO THE PLWD'S PREFERENCES (E.G., RACE/ETHNICITY, GENDER, AGE) AND OFFERS SOCIAL SUPPORT TO ENCOURAGE ADHERENCE WITH CHECK-INS, PRAISE, AND MOTIVATIONAL WORDS. OUR USER INTERFACE IS DESIGNED FOR PLWD TO EASILY SPEAK TO AND SEE THEIR PERSONAL VIRTUAL COACH ON A LARGE-SCREEN DEVICE WITH A MICROPHONE AND CAMERA (E.G., IPAD, COMPUTER). IN PHASE 1, WE WILL DEVELOP A PERSONALIZED AND CULTURALLY RESPONSIVE VIRTUAL COACH PROTOTYPE THAT DELIVERS EVIDENCE-BASED COGNITIVE AND PHYSICAL ACTIVITIES AND TEST INITIAL USABILITY/FEASIBILITY FOR RACIALLY AND ETHNICALLY DIVERSE PERSONS WITH MILD ADRD AND THEIR CAREGIVERS. BY DIGITIZING ACTIVITIES AND INCREASING PERSONAL AND CULTURAL RELEVANCE, THE COACHING PLATFORM WILL SUPPORT PLWD AND THEIR CAREGIVERS BY IMPROVING ACCESS, ENGAGEMENT, AND ADHERENCE TO EVIDENCE-BASED INTERVENTIONS TO ENHANCE HEALTH AND WELL-BEING.

Posted 5/10/23, 12:00 AM